New Editor-in-Chief and breakthrough in Diabetes
Associate Professor Sof Andrikopoulos is appointed Editor-in-Chief of the Journal of Endocrinology and Journal of Molecular Endocrinology, officially taking over from Professor Adrian Clark in November 2015. He is the first Editor-in Chief appointed outside the UK since the Journal was formed 76 years ago.
Earlier this year the Journal marked the 60th anniversary of Geoffrey Harris' ground breaking research paper "Neural control of the Pituitary Gland" which triggered the then new discipline of Neuroendocrinology.
Professor George Fink , University of Melbourne, Research Fellow at the Florey Institute, who researched with George Harris, was invited to write a thematic review for this special edition "60 Years of neuroendocrinology," "MEMOIR: Harris' neuroendocrine revolution: of portal vessels and self-priming."
"In this competitive landscape, we must ensure that we uphold the reputation we have built over the past 76 years as a leader in publishing research articles in endocrinology. This will be achieved by maintaining our high reviewing standards and continuing to accept exciting and innovative research that advances our knowledge and understanding of endocrinology," said A/Prof Andrikopoulos.
A/Professor Andrikopoulos who heads the Diabetes Laboratory in the University of Melbourne Department of Medicine at the Austin Hospital is also the President of the Australian Diabetes Society. During this period around World Diabetes Day 14th November, his current research offers renewed hope for both researchers and people affected by diabetes.
For the first time, his recently published paper, Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO mice has pinpointed a gene that directly causes defective insulin secretion resulting in the high blood sugar levels of type 2 diabetes.
"The importance of this discovery is that will it enables us to affect insulin secretion in a targeted and specific manner with the durability required to treat diabetes long term without causing cell damage," he said.